GlassScriptPhysician profile
Jennifer Rea
NPI 1386853190
$28,885.41
in general payments reported to CMS, 2019-2025
40 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $872 · 2021: $1,174 · 2022: $1,000 · 2023: $1,022 · 2024: $751 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,257.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $22,908.94 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,504.70 | 2019-2025 | Xifaxan, Trulance |
| Abbvie INC. | $1,386.40 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $403.93 | 2019-2023 | Entyvio, Gattex |
| Janssen Biotech, INC. | $320.98 | 2019-2025 | Stelara, Simponi Aria, Simponi |
| Davol INC. | $306.17 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $182.87 | 2019-2025 | Rebyota, Clenpiq |
| Qol Medical, LLC | $167.13 | 2021-2025 | Sucraid |
| Celgene Corporation | $152.04 | 2021-2024 | Zeposia |
| Janssen Scientific Affairs, LLC | $143.59 | 2024 | |
| Medtronic, INC. | $140.04 | 2022-2025 | Interstim |
| Palette Life Sciences, INC. | $125.38 | 2020 | |
| Lilly USA, LLC | $125.12 | 2023-2025 | Omvoh |
| Romark Laboratories, Lc | $89.73 | 2020 | |
| Axonics, INC. | $82.79 | 2020-2024 | Axonics |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $71.21 | 2022-2023 | Dupixent |
| Karl Storz Endoscopy-America | $70.40 | 2019 | |
| Nestle Healthcare Nutrition INC. | $62.33 | 2020-2022 | |
| Amgen INC. | $61.42 | 2022-2023 | Avsola |
| Ucb, INC. | $48.94 | 2019 | |
| Merck Sharp & Dohme LLC | $46.57 | 2019-2023 | Bridion |
| Medtronic USA, INC. | $42.59 | 2019 | |
| Covidien LP | $40.98 | 2020 | |
| Genzyme Corporation | $40.48 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $36.68 | 2020-2021 | |
| Integra Lifesciences Corporation | $33.75 | 2023 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Pfizer INC. | $33.70 | 2024-2025 | |
| Ethicon US, LLC | $31.35 | 2019-2025 | Echelon Circular |
| Tela Bio, INC. | $31.32 | 2021-2022 | |
| Eagle Pharmaceuticals, INC. | $28.48 | 2023 | |
| Evoke Pharma, INC. | $28.39 | 2021 | |
| La Jolla Pharmaceutical Company | $20.56 | 2023 | Xerava |
| Braintree Laboratories, INC. | $18.24 | 2021 | |
| Shionogi INC | $16.71 | 2020 | |
| Celltrion USA INC. | $16.10 | 2025 | Vegzelma |
| Boston Scientific Corporation | $15.27 | 2025 | Axonics |
| Ardelyx, INC. | $15.09 | 2023 | Ibsrela |
| Shire North American Group INC | $14.79 | 2019 | |
| Convatec INC. | $12.57 | 2020 | |
| Heron Therapeutics, INC. | $7.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Rea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.